Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: A proposed solution for indiscriminate antibiotic prescription

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 2 I, 2000, Pages 505-511

  Singh, Nina ^a   Rogers, Paul ^a   Atwood, Charles W ^a   Wagener, Marilyn M ^a   Yu, Victor L ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG COST; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTENSIVE CARE; LUNG INFILTRATE; LUNG LAVAGE; MAJOR CLINICAL STUDY; PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SUPERINFECTION;

EID: 0033837067     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.2.9909095     Document Type: Article

References (21)

1. Bronchoscopy should be used to diagnose nosocomial pneumonia
2. Diagnosis and treatment of ventilator-associated pneumonia - Impact on survival
3. Indications for antibiotic use in ICU patients: A one-year prospective surveillance
4. Pulmonary infiltrates in the surgical ICU
5. Antibiotic usage in an intensive care unit in a Danish university hospital
6. The prevalence of nosocomial infection in intensive care units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) study
7. Invasive diagnostic testing is not needed routinely to manage suspected ventilator-associated pneumonia
8. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic 'blind' bronchoalveolar lavage fluid
9. Isolation of Legionella pneumophila from blood with the BACTEC system: A prospective study yielding positive results
10. Antibiotic use and antibiotic resistance in the ICU: Are we curing or creating disease?
11. Evaluation of clinical judgement in the identification and treatment of nosocomial pneumonia in ventilated patients
12. Procedures for the diagnosis of pneumonia in ICU patients
13. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia
14. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia, a randomized trial
15. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia
16. Mortality and the diagnosis of ventilator-associated pneumonia, a new direction
17. Nosocomial pneumonia in mechanically ventilated adult patients: Epidemiology and prevention
18. Treatment of severe pneumonias in hospitalized patients: Results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin
19. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia
20. Antimicrobial resistance in isolates from inpatients and outpatients in United States: Increasing importance of the intensive care unit